AL002-001.xlsx

syn69045973

Created By Anh Nguyet Vu avu

Id: 2f7b8bad-6290-4abb-aaea-53436e850f23
Assay: in vivo tumor growth
assay: in vivo tumor growth
Species: Homo sapiens
StudyId: syn8012530
species: Homo sapiens
studyId: syn8012530
BodyPart: back
DataType: clinical
EntityId: syn69045973
InChIKey: CYOHGALHFOKKQC-UHFFFAOYSA-N
bodyPart: back
dataType: clinical
entityId: syn69045973
Component: ClinicalAssayTemplate
Diagnosis: Neurofibromatosis type 1
StudyName: Neurofibromatosis Type 1 Dermal Neurofibroma Longitudinal Natural History Study and Selumetinib Clinical Trial
TumorType: Cutaneous Neurofibroma
diagnosis: Neurofibromatosis type 1
studyName: Neurofibromatosis Type 1 Cutaneous Neurofibroma Longitudinal Natural History Study and Selumetinib Clinical Trial
tumorType: Cutaneous Neurofibroma
FileFormat: excel
Initiative: Francis S. Collins Scholars Program
accessType: Public Access
fileFormat: excel
initiative: Francis S. Collins Scholars Program
DataSubtype: raw
dataSubtype: raw
CompoundName: Selumetinib
IndividualID: AL002-001
ResourceType: experimentalData
compoundName: Selumetinib
individualID: AL002-001
resourceType: experimentalData
FundingAgency: NTAP
TimePointUnit: months
fundingAgency: NTAP
timePointUnit: months
ExperimentalTimepoint: 0;4;8;12;16;20;24
experimentalTimepoint: 0;4;8;12;16;20;24

AL002-001.xlsx page is loading…